OBGYN Student Guide 2014.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Gyn Oncology Colposcopy I. Basic Science/Mechanisms of Disease A
Gyn Oncology Colposcopy I. Basic Science/Mechanisms of Disease A. Genetics 1. Describe the clinical relevance of viral oncogenes. 2. Describe the role of aneuploidy in the pathogenesis of neoplasia. 3. Describe the inheritance patterns for malignancies of the pelvic organs and breast. 4. Describe the cell replication cycle, and identify the phases of the cycle most sensitive to radiation and chemotherapy. 5. Describe the genetic basis for tumor immunotherapy. B. Physiology 1. Describe the ability of vital organ systems to tolerate cancer therapy. 2. Describe the changes in cellular physiology that result from injury due to radiation and chemotherapy. 3. Describe the metabolic changes that occur in patients with a malignancy of the pelvic organs or breast. C. Embroyology 1. Describe the embryology of gonadal migration and its role in the pathogenesis of epithelial cell tumors. 2. Describe the pathogenesis of gonadal tumors in patients with gonadal dysgenesis. 3. Describe the embryologic precursors of ovarian germ cell tumors. D. Anatomy 1. Describe the gross histologic anatomy of the pelvic organs and breast. 2. Describe the vascular, lymphatic, and nerve supply to each of the pelvic organs. 3. Describe the anatomic relationship between the reproductive organs and other viscera, such as bladder, ureters, and bowel. 4. Describe the likely changes in the anatomic relationships of the pelvic and abdominal viscera created by surgical or radiation treatment for malignancy. E. Pharmacology 1. List major chemotherapeutic agents used for treatment of malignancies of the reproductive organs and breast. 2. Describe the principal adverse effects of the major chemotherapeutic agents. 3. Describe the medications of most value in treatment of complications resulting from chemotherapy and irradiation, such as: a. -
Physiology of Female Sexual Function and Dysfunction
International Journal of Impotence Research (2005) 17, S44–S51 & 2005 Nature Publishing Group All rights reserved 0955-9930/05 $30.00 www.nature.com/ijir Physiology of female sexual function and dysfunction JR Berman1* 1Director Female Urology and Female Sexual Medicine, Rodeo Drive Women’s Health Center, Beverly Hills, California, USA Female sexual dysfunction is age-related, progressive, and highly prevalent, affecting 30–50% of American women. While there are emotional and relational elements to female sexual function and response, female sexual dysfunction can occur secondary to medical problems and have an organic basis. This paper addresses anatomy and physiology of normal female sexual function as well as the pathophysiology of female sexual dysfunction. Although the female sexual response is inherently difficult to evaluate in the clinical setting, a variety of instruments have been developed for assessing subjective measures of sexual arousal and function. Objective measurements used in conjunction with the subjective assessment help diagnose potential physiologic/organic abnormal- ities. Therapeutic options for the treatment of female sexual dysfunction, including hormonal, and pharmacological, are also addressed. International Journal of Impotence Research (2005) 17, S44–S51. doi:10.1038/sj.ijir.3901428 Keywords: female sexual dysfunction; anatomy; physiology; pathophysiology; evaluation; treatment Incidence of female sexual dysfunction updated the definitions and classifications based upon current research and clinical practice. -
Sterilization and Abortion Policy Billing Instructions
Sterilization and Abortion Policy Billing Instructions Table of contents Table of contents ...................................................................................................................................... 1 Hysterectomy ............................................................................................................................................ 2 Acknowledgement forms ..................................................................................................................... 2 Prior authorization requirements ......................................................................................................... 2 Covered services ................................................................................................................................... 2 Intrauterine Devices and Subdermal Implants ......................................................................................... 4 Family planning: sterilization .................................................................................................................... 4 Prior authorization requirements ......................................................................................................... 5 Covered services ................................................................................................................................... 5 Abortion .................................................................................................................................................... 6 Claim -
Oophorectomy Or Salpingectomy— Which Makes More Sense?
Oophorectomy or salpingectomy— which makes more sense? During hysterectomy for benign indications, many surgeons routinely remove the ovaries to prevent cancer. Here’s what we know about this practice. William H. Parker, MD CASE Patient opts for hysterectomy, asks than age 45 to prevent the subsequent devel- about oophorectomy opment of ovarian cancer (FIGURES 1 and 2). Your 46-year-old patient reports increasingly The 2002 Women’s Health Initiative re- severe dysmenorrhea at her annual visit, and a port suggested that exogenous hormone use pelvic examination reveals an enlarged uterus. was associated with a slight increase in the You order pelvic magnetic resonance imaging, risk of breast cancer.2 After its publication, which shows extensive adenomyosis. the rate of oophorectomy at the time of hys- After you counsel the patient about terectomy declined slightly, likely reflect- IN THIS her options, she elects to undergo lapa- ARTICLE ing women’s desire to preserve their own roscopic supracervical hysterectomy and source of estrogen.3 For women younger Algorithm: Should asks whether she should have her ovaries than age 50, further slight declines in the rate the ovaries removed at the time of surgery. She has no of oophorectomy were seen from 2002 to be removed? family history of ovarian or breast cancer. 2010. However, in the United States, almost page 54 What would you recommend for this 300,000 women still undergo “prophylactic” woman, based on her situation and current bilateral salpingo-oophorectomy every year.4 medical research? The lifetime risk of ovarian cancer Ovarian cancer does among women with a BRCA 1 mutation not come from the prophylactic procedure should be is 36% to 46%, and it is 10% to 27% among ovary considered only if 1) there is a rea- women with a BRCA 2 mutation. -
ICD-9-CM Procedure Version 23
GEM Documentation and Users Guide 2007 version Procedure Code Set General Equivalence Mappings ICD-10-PCS to ICD-9-CM and ICD-9-CM to ICD-10-PCS 2007 Version Documentation and User’s Guide Preface Purpose and Audience This document accompanies the 2007 update of the CMS public domain reference mappings of the ICD-10 Procedure Code System (ICD-10-PCS) and ICD-9-CM Volume 3. The purpose of this document is to give potential users the information they need to understand the structure and relationships contained in the mappings so they can use them correctly. The intended audience includes but is not limited to professionals working in health information, medical research and informatics. General interest readers may find section 1 useful. Those who may benefit from the material in both sections 1 and 2 include clinical and health information professionals who plan to directly use the mappings in their work. Software engineers and IT professionals interested in the details of the file format will find this information in Appendix A. In This Document For readability, ICD-9-CM is abbreviated “I-9,” and ICD-10-PCS is abbreviated “PCS.” The network of relationships between the two code sets described herein is called the General Equivalence Mappings (GEMs). • Section 1 is a general interest discussion of mapping as it pertains to the GEMs. It includes a discussion of the difficulties inherent in linking two coding systems of very different design and structure. The specific conventions and terms employed in the GEMs are discussed in more detail. • Section 2 contains detailed information on how to use the GEM files, for users who will be working hands-on with mapping applications now or in the future—as coding experts, researchers, claims processing personnel, software developers, etc. -
Hysterectomy with Bilateral Salpingo- Oophorectomy
Hysterectomy with Bilateral Salpingo- Oophorectomy Hysterectomy is a surgical procedure to remove all or part of the uterus*, and sometimes the ovaries* and/or fallopian tubes*; a gender-affirming, masculinizing lower surgery. Oophorectomy is a surgery to remove the ovaries*; a gender-affirming, masculinizing lower surgery. How is a hysterectomy with bilateral salpingo oophorectomy performed? 1. 3 to 5 tiny incisions are made on your abdomen. 2. Gas is put into your abdomen to inflate it. 3. A very small telescope is inserted in one of the incisions so the surgeon can see inside. 4. Long, narrow instruments are inserted through the incisions to detach the uterus*, fallopian tubes*, ovaries*, and cervix*. 5. These tissues are removed through the vagina*. 6. The top of the vagina* is closed with stitches that will dissolve over time. 7. The gas is released. Will I need to stay in the hospital? You will likely be discharged the same day as the surgery What medications will I be prescribed after surgery? You will likely receive painkillers and antibiotics to reduce the chance of infection. What should I expect after my procedure? • Discomfort in your belly • Pain in your upper chest and shoulder area, due to the gas used to inflate your abdomen. • Pink, brown or yellowish brown discharge from vagina* for 4 to 6 weeks • You may pass some stitches and this is normal • Incisions may be red with some bruising. This will slowly go away. • Incisions will be closed with steri-strips, sutures or staples. Your surgeon will let you know whether and how these will be removed. -
Laparoscopic Tubal Ligation
Laparoscopic Tubal Ligation – Permanent Birth Control UR Medicine Ob/Gyn How does a tubal ligation work? A fallopian tube is attached to each side of your uterus (womb). Tubal ligation is surgery to close your fallopian tubes. It is also called female sterilization or having your "tubes tied". Your surgeon uses a laparoscope to do the surgery. This scope is a long metal tube with a magnifying camera and a light on the end. It is put into your abdomen through one or more small incisions (cuts). How is a tubal ligation performed? During a tubal ligation, your fallopian tubes are burned shut, cut, or closed with a type of clip. Immediately after your tubes are closed, sperm will not be able to reach an egg and cause pregnancy. A tubal ligation is an effective and permanent (lifelong) form of birth control. Before having this surgery, you must be sure that you never want to become pregnant in the future. You will still have monthly periods after your tubal ligation. A tubal ligation will not protect you from sexually transmitted diseases. Are there any side effects or risks? There are always risks with surgery. During any surgery, you may bleed more than usual, have trouble breathing, or get an infection. Blood vessels or organs such as your bowel or bladder could be injured during surgery. Although pregnancy is unlikely after a tubal ligation, there is a small chance of it. If pregnancy does occur, there is an increased risk of having an ectopic pregnancy (pregnancy in the tubes). A tubal ligation can be reversed but it does not mean you will be able to get pregnant again. -
The Costs and Benefits of Moving to the ICD-10 Code Sets
CHILDREN AND ADOLESCENTS This PDF document was made available from www.rand.org as a public CIVIL JUSTICE service of the RAND Corporation. EDUCATION ENERGY AND ENVIRONMENT Jump down to document HEALTH AND HEALTH CARE 6 INTERNATIONAL AFFAIRS POPULATION AND AGING The RAND Corporation is a nonprofit research PUBLIC SAFETY SCIENCE AND TECHNOLOGY organization providing objective analysis and effective SUBSTANCE ABUSE solutions that address the challenges facing the public TERRORISM AND HOMELAND SECURITY and private sectors around the world. TRANSPORTATION AND INFRASTRUCTURE U.S. NATIONAL SECURITY Support RAND Purchase this document Browse Books & Publications Make a charitable contribution For More Information Visit RAND at www.rand.org Explore RAND Science and Technology View document details Limited Electronic Distribution Rights This document and trademark(s) contained herein are protected by law as indicated in a notice appearing later in this work. This electronic representation of RAND intellectual property is provided for non-commercial use only. Permission is required from RAND to reproduce, or reuse in another form, any of our research documents for commercial use. This product is part of the RAND Corporation technical report series. Reports may include research findings on a specific topic that is limited in scope; present discus- sions of the methodology employed in research; provide literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research profes- sionals, and supporting documentation; -
Tubal Ligation (Laparoscopic Sterilization)
AQ The American College of Obstetricians and Gynecologists FREQUENTLY ASKED QUESTIONS FAQ035 CONTRACEPTION Sterilization by Laparoscopy • What is sterilization? • What is laparoscopy? f • Does sterilization protect against sexually transmitted diseases (STDs)? • What should I consider before having sterilization? • Can all women have laparoscopic sterilization? • How is laparoscopic sterilization done? • What are the benefits of laparoscopic sterilization? • What are the risks of laparoscopic sterilization? • What should I expect after surgery? • Glossary What is sterilization? Sterilization is surgery performed to prevent a woman from getting pregnant. It is meant to be permanent. With tubal sterilization, both fallopian tubes are blocked by tying, sealing, or attaching a ring or clip to them. The egg then cannot move down the tube to the uterus and the sperm cannot reach the egg. This prevents pregnancy. Sterilization often is done with a technique called laparoscopy. What is laparoscopy? Laparoscopy is a way of doing surgery. In laparoscopy, a device like a small telescope called a laparoscope is inserted into the pelvic cavity through a small incision. Laparoscopy can be done as an outpatient procedure. This means you usually can go home the same day. Does sterilization protect against sexually transmitted diseases (STDs)? Sterilization does not protect against sexually transmitted diseases (STDs) (see the FAQ How to Prevent Sexually Transmitted Diseases). If you are at risk of getting an STD, you still need to protect yourself by using condoms. What should I consider before having sterilization? Sterilization is a permanent method of birth control. You and your partner must be certain that you do not want any more children—now or in the future. -
Cervical Cancer Screening for Pcps
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines June 2015 General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early detection of cervical intraepithelial neoplasia. Recently, increasing understanding of the role of high risk strains of the Human Papilloma Virus in the development of invasive cervical cancer, and the ability to test for these strains has begun to affect the screening guidelines for cervical cancer. In particular, the ability to screen specifically for HPV 16/18 has changed the guidelines drastically. It must be remembered though, that despite these improvements, the majority of invasive cervical cancers in the US are in women who have never been screened or have not been screened in the last five years, and these women are often in underserved patient populations. Technological advances in screening techniques will only offer a significant improvement in overall cancer incidence if they reach all women in the US. These clinical practice guidelines for Pap Smear Screening assist primary care clinicians by providing an evidence-based analytical framework for the evaluation and treatment of patients. They are not intended to replace a clinician’s judgment or to establish a protocol for all patients with a particular condition. In particular, women with a history of CIN2, CIN3, Adenocarcinoma in situ, or cervical cancer, women exposed in-utero to diethylstilbestrol, and women who are immunocompromised are not addressed in these recommendations. Furthermore, this guideline does not address the follow up testing intervals and triage of results of testing after colposcopy. -
2021 Biennial Report to Legislature and Governor
May 2021 Prioritization of Health Services A Report to the Governor and the 81st Oregon Legislature HEALTH EVIDENCE REVIEW COMMISSION Acknowledgments Authors Jason Gingerich Ariel Smits, M.D., M.P.H. Others contributing to the report Liz Walker, Ph.D., M.P.H. Daphne Peck Contact person, information Jason Gingerich at [email protected] or 503-385-3594 421 SW Oak St., Suite 775 Portland, OR 97204 Health Evidence Review Commission Health Policy and Analytics Oregon Health Authority 2021 II Prioritization of Health Services Contents » Acknowledgments ................................................................................... II » Executive summary ................................................................................IV » Charge to the Health Evidence Review Commission ...............................1 » The prioritization methodology ................................................................3 » Biennial review of the Prioritized List ......................................................5 » Other biennial review changes .............................................................6 » Interim modifications to the Prioritized List ............................................7 » Recommendations ...................................................................................8 » Appendix A: Commission and subcommittee membership .....................9 » Health Evidence Review Commission members ....................................9 » Value-based Benefits Subcommittee members ................................. -
Obstetrics & Gynecology
Obstetrics & Gynecology CARLOS I. GABRIEL, M.D. Board Certified Diplomat of the American Board of Obstetrics & Gynecology Medical Director of the Better Bladder Center Medical Degree University of Miami School of Medicine Miami, Florida 1995-1999 Obstetrics & Gynecology Residency University of Miami/ Jackson Healthcare System Miami, Florida 1999-2003 Se Habla Espanol Dr. Gabriel specializes in: • Conservative and surgical management of urinary incontinence and pelvis floor relaxation • In-office management of persistent bleeding • Minimally-invasive surgery for chronic pelvic pain, endometriosis, peristent bleeding, infertility and uterine fibroids A note from Dr. Gabriel: “Patients need to know that there are a multitude of non-medicinal and nonsurgical treatments now available in Polk County for the treatment of the various kinds of urinary incontinence. I like spending time with patients, listening to their concerns and connecting with them as people. My staff and I treat our patients like family.” “treating GOLDyou PM S 1245 well ... PURPLE since PMS 268 1948” Carlos I. Gabriel, M.D. Phone: 863-293-1191 Obstetrics and Gynecology Ext. 3573 Board Certified Fax: 863-293-6819 Diplomat of the American Board of Obstetrics & Gynecology Medical Director of the Better Bladder Center Emergency After Hours: 863-293-1121 Bond Clinic Women’s Health Center 199 Avenue B NW www.BondClinic.com Winter Haven, FL 33881 GOLD PM S 1245 PURPLE PMS 268 Obstetrics & Gynecology Dr. Gabriel’s priority is to provide a safer and more effective alternative to traditional open surgery for all conditions. He provides treatment for: Pelvic Floor Relaxation: cystocoele, rectocoele, enterocoele, uterine/vaginal prolapse Urinary Incontinence: • Dr.